In the News

Recent Coverage of HMS in the News
October 25, 2012

Physician health programs in most states are designed to help doctors with substance-use and other problems get the care they need and, when appropriate, return to work while protecting patient safety. But two Harvard doctors who have been involved with the Massachusetts program say there is too little oversight of operations in programs across the country and no clear standards. J. Wesley Boyd, HMS assistant clinical professor of psychiatry at Cambridge Health Alliance and John R. Knight, HMS associate professor of pediatrics at Boston Children’s Hospital, authored a review article about this issue.

October 25, 2012

Recognizing the possibility of failure is a key to excellence in both teaching and medicine, Atul Gawande, HMS professor of surgery at Brigham and Women’s Hospital, said at a lecture at the Graduate School of Education Wednesday.

October 25, 2012

The main supporter and main opponent of the ballot question have appeared on WBUR in recent weeks to debate the merits of assisted suicide. Now, they speak with WBUR’s All Things Considered host Sacha Pfeiffer about their very personal reasons for their stances. Marcia Angell, HMS senior lecturer on social medicine, is one of the participants.

October 24, 2012

A majority of patients with advanced lung and colorectal cancer harbor the fundamental misperception that treatments that can extend life and alleviate pain might also cure them, according to a new study. Jane Weeks, HMS professor of medicine at Dana-Farber Cancer Institute, led the team. Deborah Schrag, HMS associate professor of medicine at Dana-Farber Cancer Institute, is a co-author. David Ryan, HMS associate professor of medicine at Massachusetts General Hospital, is also quoted.

October 24, 2012

Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer's disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014. Alvaro Pascual-Leone, HMS professor of neurology at Beth Israel Deaconess Medical Center, is leading a trial of the system.

October 24, 2012

An HMS-affiliated hospital is backing away from its decision to promote a paper linking the artificial sweetener aspartame and cancer, now saying the evidence was “weak.”

October 24, 2012

Aspirin, one of the world’s oldest and cheapest drugs, has shown remarkable promise in treating colon cancer in people with mutations in a gene that’s thought to play a role in the disease. Among patients with the mutations, those who regularly took aspirin lived longer than those who didn’t, a major study found. Andrew Chan, HMS associate professor of medicine at Massachusetts General Hospital, led the study.

October 24, 2012

A patient’s genetic makeup may explain the “placebo effect,” in which people perceive that a fake treatment makes them feel better, according to a study that may help researchers design better clinical trials. Kathryn Hall, HMS research fellow in medicine at Beth Israel Deaconess Medical Center, is the lead author. Ted Kaptchuk, HMS associate professor of medicine at Beth Israel Deaconess Medical Center, is also an author of the study.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.